Chimeric Antigen Receptor T-cells (CARs) in Cancer Treatment.

Zam, Wissam; Assaad, Amany

Zam, Wissam; Assaad, Amany.

Affiliation

Zam W; Department of Analytical and Food Chemistry, Faculty of Pharmacy, Al-Wadi International University, Homs, Syria.
Assaad A; Department of Analytical and Food Chemistry, Faculty of Pharmacy, Tartous University, Tartous, Syria.

Curr Mol Pharmacol ; 15(3): 532-546, 2022.

Article in En | MEDLINE | ID: mdl-34382510

Subject(s)

Hematologic Neoplasms; Neoplasms; Receptors, Chimeric Antigen; Hematologic Neoplasms/therapy; Humans; Immunotherapy, Adoptive; Neoplasms/therapy; Quality of Life; T-Lymphocytes

Key words

CAR T-cells; Immunotherapy; challenges; hematologic malignancies; review; solid tumors

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hematologic Neoplasms / Receptors, Chimeric Antigen / Neoplasms Limits: Humans Language: En Journal: Curr Mol Pharmacol Journal subject: FARMACOLOGIA Year: 2022 Type: Article Affiliation country: Syria

Fulltext

XML

PubMed Links

Search on Google